Glaxo Settles Patent Suit Over Paxil
GlaxoSmithKline settled a lawsuit against Synthon Pharmaceuticals, clearing the way for generic drug maker to immediately start selling Pexeva, its competitor to the U.K. pharmaceutical giant's antidepressant Paxil....To view the full article, register now.
Already a subscriber? Click here to view full article